Cardiac arrhythmia is one of the leading causes of sudden death in developed countries, and results from abnormal cardiac electrical activity. Regular beat-to-beat cardiac excitability requires the coordinated activity of membrane bound ionophoric proteins which are channels and transporters. Aberrant currents can result from either changes in the gating properties of ionophores or altered trafficking to their appropriate membrane subdomain. Mutations in the genes of ionophoric proteins result in inherited human arrhythmogenic syndromes. While mutations of channel proteins can affect biophysical gating properties 1 , most inherited arrhythmia disorders likely result from altered protein trafficking rather than gating [2] [3] [4] [5] . In addition, mutations in the proteins that make up the trafficking apparatus, namely the cytoskeletal and associated proteins, can also result in arrhythmia disorders.
Ankyrins are an important family of cytoskeleton related adapter proteins known for localizing proteins to specialized subdomains in a variety of cells types 1 . Ankyrins interact with ionophoric proteins, whereas their central domain binds to members of the -spectrin family of actin-associated cytoskeleton, thereby linking the channel to the actin cytoskeleton. Ankyrins in the vertebrate heart are encoded by three genes: ankyrin-R (ANK1), ankyrin-B (ANK2) and ankyrin-G (ANK3), with the ankyrin-B gene product being critical for localizing the Na/Ca exchanger and Na/K ATPase to the plasma membrane and inositol 1,4,5 trisphosphate (IP3) receptor to the sarcoplasmic reticulum 6 . The study in the current issue by Smith et al 7 reports a novel human mutation in ankyrin-B (ANK2) gene that results in recurrent ventricular fibrillation.
It is a single amino acid substitution at a highly conserved residue p.R990Q, which locates at a spectrin binding domain on ankyrin-B that is far upstream of the ankyrin-B C-terminal domains, where all previous mutations were identified. Although in silico modeling shows that the mutation is not on the interaction interface between ankyrin-B and II-spectrin, binding of IIcytoskeletal and associated proteins, can also result in arrhythmia disorders.
Ankyrins are an important family of cytoskeleton related adapter proteins known for o oca ca ali li lizi zi zing ng g p p pro ro otein in ns s s to t specialized subdomains in n n a a a v v variety of cells s t types es s 1 . . Ankyrins interact with o ono o oph p oric pro ote tein n ns, w w whe he ere reas as s t t th he heir ir r c c cen ent tr ra al do o om m main n n b b binds ds ds t to o me mem mb be ers of of f t th he he --s -spe pec ct ctri ri rin n f f fam mi mily ly y o o of ac acti ti tin-n-n as as asso so soci ci ciat a ated ed cyt yt ytos os oske ke el l let eton n n, , , th th her er ereb eb eby y li link nk nkin in ing g g th th the e e ch ch han an anne ne el l l t to to t t th h he e ac ac acti ti tin n c cy cyto to tosk sk kel el elet et eton on on. A A Ank k kyr yr y in in ins s in in he vertebra ate te te h h hea ea eart rt rt a a are re re e e enc nc cod od oded ed d b b by y th th t re re ee e e ge ge gene ne nes: s: a a ank nk nkyr yr y in n n-R -R -R ( ( (AN AN ANK1 K1 K ), ), ), a a ank nk nkyr yr yrin in in-B -B B ( ( (AN AN ANK2 K K ) and by guest on April 13, 2017 http://circ.ahajournals.org/ Downloaded from spectrin to the mutated p.R990Q ankyrin-B is greatly impaired when tested in vitro. Therefore, the authors proposed a model in which II-spectrin recruits ankyrin-B and targets ionophore proteins to the membrane, regulating cardiac excitability. The novelty in this finding relates to the independence of the mutation to ionophore proteins. Not only is the mutation in a cytoskeleton adaptor protein (ankyrin-B), but it affects a cytoskeletal attachment domain rather than an ion channel binding domain, much in the way that mutations in the structural protein desmoplakin affects binding of the microtubule plus-end protein EB1, affecting Connexin43 delivery to intercalated discs. 8 The proband in the study by Smith et al 7 in this issue of Circulation was reported to have a prolonged QTc. Causality of the p.R990Q mutation in ankyrin-B was established primarily by examining the phenotype of a mouse model with cardiac specific deletion of II-spectrin. The assumption in the spectrin knockout model is that removing spectrin is the functional equivalent of a mutation decreasing spectrin's ability to bind ankyrin-B. The knockout mouse recapitulated long QT, and also was notable for nodal dysfunction including bradycardia, AV block, and stress-induced ventricular ectopy. In addition, the authors found that the ryanodine receptor (RyR2) protein was dramatically reduced due to loss of II-spectrin, and imaging indicated smaller RyR2 clusters as well. These findings help explain the aberrant calcium handling observed in isolated cardiomyocytes and in vivo arrhythmogenic phenotype. The study also demonstrated changes in previously known molecular partners of ankyrin-B such as Na/Ca exchanger and Na/K ATPase, thus highlighting the significance of II-spectrin/ankyrin-B cytoskeletal complex in vivo. Overall, the data strongly support an important role of II-spectrin in maintaining ionophore integrity required for electrical health of the heart.
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With regards to trafficking, the authors report that II-spectrin plays central roles in organizing membrane proteins. Caution should be used in presuming trafficking involves forward trafficking only, and not considering potential intramembrane movements or internalization (retrograde trafficking). 9 A thorough characterization of dynamics of protein trafficking in which forward, intramembrane, and retrograde trafficking are isolated and examined in dynamic detail will help elucidate the mechanisms by which II-spectrin affects ion channel localization. For instance, according to the Targeted Delivery paradigm, both
Connexin43 and the Cav1.2 are forward trafficked using microtubule highways, and membrane scaffolds 10, 11 , and Connexin43 is internalized by a cascade of phosphorylation events leading to ubiquitination 12 . Do ankyrin-B and II-spectrin regulate forward trafficking or internalization?
Despite the severity of arrhythmias associated with p.R990Q mutation in ankyrin-B, this is a rare mutation with allele frequency of ~0.007%. Key trafficking proteins that change in acquired heart failure may be causally associated with common arrhythmias and commonly occurring decreased excitation-contraction coupling. For instance, EB1, which aids Connexin43 forward trafficking, is displaced from microtubules in acquired heart failure, decreasing
Connxin43 delivery to the intercalated disc 13 . Also the actin and microtubule anchoring protein BIN1, which also folds T-tubule membrane 14 and facilitates forward delivery of Cav1.2 channels 11 , is decreased in failing human and animal heart 15, 16 . Fortunately, with BIN1, its heart failure. The change in -tubulin concentration with II-spectrin knockdown 7 suggests that if II-spectrin is diminished in acquired heart failure, it may also affect ionophore trafficking.
Smith et al 7 are to be congratulated on advancing ankyrin-B studies to not only finding that mutations of its cytoskeleton attachment domains can be related to human arrhythmia, but that the ankyrin-B/ II-spectrin interaction underlies critical ionophore protein localization and expression levels of key excitation-contraction coupling proteins. As a result, we speculate, and frankly encourage, greater interest in cytoskeleton regulation of electrophysiology. As more is learned about the complex interaction between cytoskeletal and ionophore proteins, the lessons learned will be applied not just to patients with inherited disease, but to the common and growing number of patients with acquired heart failure. 
Conflict of Interest Disclosures:
None.
